Art's-Way Manufacturing (ARTW) vs Niki BioSolutions (NIKI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Art's-Way Manufacturing (ARTW) has outperformed Niki BioSolutions (NIKI) over the past year, gaining 8.6% versus a loss of 83.1%. Over five years, ARTW leads with a +4.1% price change compared with -98.5% for NIKI. Art's-Way Manufacturing is the larger company by market cap ($18.4 million vs $12.5 million), about 1.5 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ARTW | NIKI |
|---|---|---|
| Share price | $3.54 | $4.00 |
| Market cap | $18.41M | $12.47M |
| 1-day change | -3.54% | -7.41% |
| YTD return | +50.64% | -62.26% |
| 1-year return | +8.59% | -83.12% |
| 5-year return | +4.12% | -98.46% |
| EPS (TTM) | $-0.01 | $-2.69 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.17 | $17.60 |
| 52-week low | $2.05 | $4.00 |
| Distance from 52-week high | -15.11% | -77.27% |
| Average volume | 544.64K | 157.63K |
| Shares outstanding | 5.20M | 2.94M |
| Employees | 95 | 1 |
| Sector | Industrials | Industrials |
| Industry | Industrial Machinery/Components | Industrial Machinery/Components |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ARTW has outperformed NIKI by 91.7 percentage points over the past year.
About Art's-Way Manufacturing
ARTW stock →Art's-Way Manufacturing Co., Inc. manufactures and sells agricultural equipment, and specialized modular science and agricultural buildings in the United States and internationally.
Industrials · Industrial Machinery/Components · 95 employees
About Niki BioSolutions
NIKI stock →Niki BioSolutions, Inc., through its subsidiaries, operates as a clinical-stage biopharmaceutical company and engages in the discovery, development, and commercialization of therapeutic products to treat oncology and infectious diseases. Its pipeline products include SACT-1, a repurposed drug candidate, which is in a Phase 1 clinical trial to treat neuroblastoma and other cancer types; ALS-4, a repurposed small molecule, which is in a Phase 1 clinical trial for the treatment of bacterial infections, such as staphylococcus aureus, mycobacterium tuberculosis, and pseudomonas aeruginosa.
Industrials · Industrial Machinery/Components · 1 employees
ARTW vs NIKI FAQ
Which is bigger, Art's-Way Manufacturing or Niki BioSolutions?
Art's-Way Manufacturing (ARTW) is larger, with a market capitalization of $18.41M compared with $12.47M for Niki BioSolutions (NIKI).
Which stock has performed better over the past year, ARTW or NIKI?
ARTW returned +8.59% over the past 12 months, compared with -83.12% for NIKI (price return, excluding dividends). Past performance does not predict future results.
Are Art's-Way Manufacturing and Niki BioSolutions in the same industry?
Yes. Both are classified in the Industrial Machinery/Components industry within the Industrials sector.